期刊
JOURNAL OF EXPERIMENTAL MEDICINE
卷 207, 期 3, 页码 455-463出版社
ROCKEFELLER UNIV PRESS
DOI: 10.1084/jem.20091725
关键词
-
资金
- Australian National Health and Medical Research Council (NHMRC)
- United States Public Health Service [AI23990, AI070813, CA72074]
Mast cell production of interleukin-10 (IL-10) can limit the skin pathology induced by chronic low-dose ultraviolet (UV)-B irradiation. Although the mechanism that promotes mast cell IL-10 production in this setting is unknown, exposure of the skin to UVB irradiation induces increased production of the immune modifying agent 1 alpha, 25-dihydroxyvitamin D-3 (1 alpha, 25[OH](2)D-3). We now show that 1 alpha, 25(OH)(2)D-3 can up-regulate IL-10 mRNA expression and induce IL-10 secretion in mouse mast cells in vitro. To investigate the roles of 1 alpha, 25(OH)(2)D-3 and mast cell vitamin D receptor (VDR) expression in chronically UVB-irradiated skin in vivo, we engrafted the skin of genetically mast cell-deficient WBB6F(1)-Kit(W/W-v) mice with bone marrow-derived cultured mast cells derived from C57BL/6 wild-type or VDR-/- mice. Optimal mast cell-dependent suppression of the inflammation, local production of proinflammatory cytokines, epidermal hyperplasia, and epidermal ulceration associated with chronic UVB irradiation of the skin in Kit(W/W-v) mice required expression of VDR by the adoptively transferred mast cells. Our findings suggest that 1 alpha, 25(OH)(2)D-3/VDR-dependent induction of IL-10 production by cutaneous mast cells can contribute to the mast cell's ability to suppress inflammation and skin pathology at sites of chronic UVB irradiation.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据